Skip to main content

Advertisement

Log in

Protective Effects of Alisol B 23-Acetate Via Farnesoid X Receptor-Mediated Regulation of Transporters and Enzymes in Estrogen-Induced Cholestatic Liver Injury in Mice

  • Research Paper
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose

To investigate protective effects of alisol B 23-acetate (AB23A) against hepatotoxity and cholestasis induced by 17α-ethinylestradiol (EE) in association with farnesoid X receptor (FXR) activation in vivo and in vitro.

Methods

The cholestatic liver injury model was established by subcutaneous injections of EE in C57BL/6 mice. Serum biomarkers, bile flow assay and H&E staining were used to identify the amelioration of cholestasis after AB23A treatment. Mice primary hepatocytes culture, gene silencing experiment, real-time PCR and Western blot assay were used to elucidate the mechanisms underlying AB23A hepatoprotection.

Results

AB23A treatment protected against liver injury induced by EE through increasing hepatic efflux and reducing uptake of bile acid via an induction in efflux transporters (Bsep and Mrp2) and an inhibition in hepatic uptake transporter (Ntcp) expression. AB23A also reduced bile acid synthesis through repressing Cyp7a1 and Cyp8b1, and increased bile acid metabolism through an induction in gene expression of Sult2a1. We further demonstrated that the changes in transporters and enzymes, as well as ameliorative liver histology in AB23A-treated mice were abrogated by FXR antagonist guggulsterone in vivo and were abrogated after FXR was silenced in vitro.

Conclusions

AB23A produces protective effects against EE-induced cholestasis, due to FXR-mediated gene regulation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Abbreviations

AB23A:

Alisol B 23-acetate

ALP:

Alkaline phosphatase

Bsep:

Bile salt export pump

CAR:

Constitutive androstane receptor

CDCA:

Chenodeoxycholic acid

Cyp7a1:

Cholesterol 7α-hydroxylase

Cyp8b1:

Sterol-12α-hydroxylase

EE:

17α-ethinylestradiol

Fgf15:

fibroblast growth factor 15

FXR:

Farnesoid X receptor

GS:

Guggulsterone

H&E:

Haematoxylin & eosin

Mrp2:

Multidrug resistance-related protein 2

Ntcp:

Na+/taurocholate cotransporting polypeptide

PXR:

Pregnane X receptor

Shp:

Small heterodimer partner

Sult2a1:

Hydroxysteroid sulfotransferase 2a1

Ugt1a1:

UDP-glucuronosyltransferase 1a1

References

  1. Williamson C, Miragoli M, Sheikh Abdul Kadir S, Abu-Hayyeh S, Papacleovoulou G, Geenes V, et al. Bile acid signaling in fetal tissues: implications for intrahepatic cholestasis of pregnancy. Dig Dis. 2011;29:58–61.

    Article  PubMed  Google Scholar 

  2. Paulen ME, Folger SG, Curtis KM, Jamieson DJ. Contraceptive use among solid organ transplant patients: a systematic review. Contraception. 2010;82:102–12.

    Article  PubMed  Google Scholar 

  3. Vihma V, Ropponen A, Aittomaki K, Ylikorkala O, Tikkanen MJ. Postmenopausal estrogen therapy and serum estradiol fatty acid esters in women with and without previous intrahepatic cholestasis of pregnancy. Ann Med. 2004;36:393–9.

    Article  CAS  PubMed  Google Scholar 

  4. Henriquez-Hernandez LA, Flores-Morales A, Santana-Farre R, Axelson M, Nilsson P, Norstedt G, et al. Role of pituitary hormones on 17alpha-ethinylestradiol-induced cholestasis in rat. J Pharmacol Exp Ther. 2007;320:695–705.

    Article  CAS  PubMed  Google Scholar 

  5. Forman BM, Goode E, Chen J, Oro AE, Bradley DJ, Perlmann T, et al. Identification of a nuclear receptor that is activated by farnesol metabolites. Cell. 1995;81:687–93.

    Article  CAS  PubMed  Google Scholar 

  6. Wang YD, Chen WD, Moore DD, Huang W. FXR: a metabolic regulator and cell protector. Cell Res. 2008;18:1087–95.

    Article  CAS  PubMed  Google Scholar 

  7. Matsubara T, Li F, Gonzalez FJ. FXR signaling in the enterohepatic system. Mol Cell Endocrinol. 2013;368:17–29.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Modica S, Petruzzelli M, Bellafante E, Murzilli S, Salvatore L, Celli N, et al. Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis. Gastroenterology. 2012;142:355–65.

    Article  CAS  PubMed  Google Scholar 

  9. Fiorucci S, Mencarelli A, Distrutti E, Palladino G, Cipriani S. Targetting farnesoid-X-receptor: from medicinal chemistry to disease treatment. Curr Med Chem. 2010;17:139–59.

    Article  CAS  PubMed  Google Scholar 

  10. Kong B, Wang L, Chiang JY, Zhang Y, Klaassen CD, Guo GL. Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice. Hepatology. 2012;56:1034–43.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  11. Wooton-Kee CR, Coy DJ, Athippozhy AT, Zhao T, Jones BR, Vore M. Mechanisms for increased expression of cholesterol 7alpha-hydroxylase (Cyp7a1) in lactating rats. Hepatology. 2010;51:277–85.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Jiang ZY, Zhang XM, Zhang FX, Liu N, Zhao F, Zhou J, et al. A new triterpene and anti-hepatitis B virus active compounds from Alisma orientalis. Planta Med. 2006;72:951–4.

    Article  CAS  PubMed  Google Scholar 

  13. Xu YH, Zhao LJ, Li Y. Alisol B acetate induces apoptosis of SGC7901 cells via mitochondrial and phosphatidylinositol 3-kinases/Akt signaling pathways. World J Gastroenterol. 2009;15:2870–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  14. Jin HG, Jin Q, Ryun Kim A, Choi H, Lee JH, Kim YS, et al. A new triterpenoid from Alisma orientale and their antibacterial effect. Arch Pharm Res. 2012;35:1919–26.

    Article  CAS  PubMed  Google Scholar 

  15. Meng Q, Chen X, Wang C, Liu Q, Sun H, Sun P, et al. Alisol B 23-acetate promotes liver regeneration in mice after partial hepatectomy via activating farnesoid X receptor. Biochem Pharmacol. 2014;92:289–98.

    Article  CAS  PubMed  Google Scholar 

  16. Meng Q, Chen X, Wang C, Liu Q, Sun H, Sun P, et al. Alisol B 23-acetate protects against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes involved in bile acids homeostasis. Toxicol Appl Pharmacol. 2015;283:178–86.

    Article  CAS  PubMed  Google Scholar 

  17. Mencarelli A, Renga B, Palladino G, Distrutti E, Fiorucci S. The plant sterol guggulsterone attenuates inflammation and immune dysfunction in murine models of inflammatory bowel disease. Biochem Pharmacol. 2009;78:1214–23.

    Article  CAS  PubMed  Google Scholar 

  18. Klaunig JE, Goldblatt PJ, Hinton DE, Lipsky MM, Chacko J, Trump BF. Mouse liver cell culture. I. Hepatocyte isolation. In Vitro. 1981;17:913–25.

    Article  CAS  PubMed  Google Scholar 

  19. Sanchez Pozzi EJ, Crocenzi FA, Pellegrino JM, Catania VA, Luquita MG, Roma MG, et al. Ursodeoxycholate reduces ethinylestradiol glucuronidation in the rat: role in prevention of estrogen-induced cholestasis. J Pharmacol Exp Ther. 2003;306:279–86.

    Article  CAS  PubMed  Google Scholar 

  20. Corpechot C. Primary biliary cirrhosis and bile acids. Clin Res Hepatol Gastroenterol. 2012;36:70016–5.

    Article  Google Scholar 

  21. Wagner M, Zollner G, Trauner M. Nuclear receptors in liver disease. Hepatology. 2011;53:1023–34.

    Article  CAS  PubMed  Google Scholar 

  22. Chen J, Zhao KN, Liu GB. Estrogen-induced cholestasis: pathogenesis and therapeuticimplications. Hepatogastroenterology. 2013;60:1289–96.

    CAS  PubMed  Google Scholar 

  23. Boaglio AC, Zucchetti AE, Sanchez Pozzi EJ, Pellegrino JM, Ochoa JE, Mottino AD, et al. Phosphoinositide 3-kinase/protein kinase B signaling pathway is involved in estradiol 17beta-D-glucuronide-induced cholestasis: complementarity with classical protein kinase C. Hepatology. 2010;52:1465–76.

    Article  CAS  PubMed  Google Scholar 

  24. Ruiz ML, Villanueva SS, Luquita MG, Ikushiro S, Mottino AD, Catania VA. Beneficial effect of spironolactone administration on ethynylestradiol-induced cholestasis in the rat: involvement of up-regulation of multidrug resistance-associated protein 2. Drug Metab Dispos. 2007;35:2060–6.

    Article  CAS  PubMed  Google Scholar 

  25. Alrefaiand WA, Gill RK. Bile acid transporters: structure, function, regulation and pathophysiological implications. Pharm Res. 2007;24:1803–23.

    Article  Google Scholar 

  26. Huang W, Ma K, Zhang J, Qatanani M, Cuvillier J, Liu J, et al. Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration. Science. 2006;312:233–6.

    Article  CAS  PubMed  Google Scholar 

  27. Yang H, Ramani K, Xia M, Ko KS, Li TW, Oh P, et al. Dysregulation of glutathione synthesis during cholestasis in mice: molecular mechanisms and therapeutic implications. Hepatology. 2009;49:1982–91.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  28. Nicolaou M, Andress EJ, Zolnerciks JK, Dixon PH, Williamson C, Linton KJ. Canalicular ABC transporters and liver disease. J Pathol. 2012;226:300–15.

    Article  CAS  PubMed  Google Scholar 

  29. Blazquez AG, Briz O, Romero MR, Rosales R, Monte MJ, Vaquero J, et al. Characterization of the role of ABCG2 as a bile acid transporter in liver and placenta. Mol Pharmacol. 2012;81:273–83.

    Article  CAS  PubMed  Google Scholar 

  30. Gundala S, Wells LD, Milliano MT, Talkad V, Luxon BA, Neuschwander-Tetri BA. The hepatocellular bile acid transporter Ntcp facilitates uptake of the lethal mushroom toxin alpha-amanitin. Arch Toxicol. 2004;78:68–73.

    Article  CAS  PubMed  Google Scholar 

  31. Herraez E, Gonzalez-Sanchez E, Vaquero J, Romero MR, Serrano MA, Marin JJ, et al. Cisplatin-induced chemoresistance in colon cancer cells involves FXR-dependent and FXR-independent up-regulation of ABC proteins. Mol Pharm. 2012;9:2565–76.

    Article  CAS  PubMed  Google Scholar 

  32. Fiorucci S, Antonelli E, Rizzo G, Renga B, Mencarelli A, Riccardi L, et al. The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis. Gastroenterology. 2004;127:1497–512.

    Article  CAS  PubMed  Google Scholar 

  33. Kir S, Zhang Y, Gerard RD, Kliewer SA, Mangelsdorf DJ. Nuclear receptors HNF4alpha and LRH-1 cooperate in regulating Cyp7a1 in vivo. J Biol Chem. 2012;287:41334–41.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  34. Fiorucci S, Clerici C, Antonelli E, Orlandi S, Goodwin B, Sadeghpour BM, et al. Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen-induced cholestasis. J Pharmacol Exp Ther. 2005;313:604–12.

    Article  CAS  PubMed  Google Scholar 

  35. Staudinger JL, Woody S, Sun M, Cui W. Nuclear-receptor-mediated regulation of drug- and bile-acid-transporter proteins in gut and liver. Drug Metab Rev. 2013;45:48–59.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

ACKNOWLEDGMENTS AND DISCLOSURES

This present study was financially supported by a grant from the National Natural Science Foundation of China (Nos. 81302826, 81273580). The authors declare that there are no conflicts of interest.

Author Contributions

Qiang Meng: Study conception and design; Drafting/revision of the work for intellectual content and contex

Xinli Chen: Acquisition, analysis of data

Changyuan Wang: Acquisition, analysis of data

Qi Liu: Drafting/revision of the work for intellectual content and context

Huijun Sun: Study conception and design

Pengyuan Sun: Acquisition, analysis of data

Xiaokui Huo: Drafting/revision of the work for intellectual content and contex

Zhihao Liu: Acquisition, analysis of data

Jihong Yao: Drafting/revision of the work for intellectual content and contex

Kexin Liu: Final approval and overall responsibility for the published work

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kexin Liu.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Meng, Q., Chen, X., Wang, C. et al. Protective Effects of Alisol B 23-Acetate Via Farnesoid X Receptor-Mediated Regulation of Transporters and Enzymes in Estrogen-Induced Cholestatic Liver Injury in Mice. Pharm Res 32, 3688–3698 (2015). https://doi.org/10.1007/s11095-015-1727-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11095-015-1727-x

KEY WORDS

Navigation